75 related articles for article (PubMed ID: 15278342)
1. High-throughput chemiluminometric determination of prostate-specific membrane antigen mRNA in peripheral blood by RT-PCR using a synthetic RNA internal standard.
Emmanouilidou E; Ioannou PC; Christopoulos TK
Anal Bioanal Chem; 2004 Sep; 380(1):90-7. PubMed ID: 15278342
[TBL] [Abstract][Full Text] [Related]
2. Determination of prostate specific antigen mRNA in peripheral blood by reverse transcriptase polymerase chain reaction and a simple chemiluminometric hybridization assay in a high-throughput format.
Emmanouilidou E; Ioannou PC; Christopoulos TK; Polizois K
Anal Biochem; 2003 Feb; 313(1):97-105. PubMed ID: 12576064
[TBL] [Abstract][Full Text] [Related]
3. Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer.
Stathopoulou A; Angelopoulou K; Perraki M; Georgoulias V; Malamos N; Lianidou E
Clin Biochem; 2001 Nov; 34(8):651-9. PubMed ID: 11849626
[TBL] [Abstract][Full Text] [Related]
4. Quantification of prostate-specific antigen mRNA by coamplification with a recombinant RNA internal standard and microtiter well-based hybridization.
Verhaegen M; Ioannou PC; Christopoulos TK
Clin Chem; 1998 Jun; 44(6 Pt 1):1170-6. PubMed ID: 9625039
[TBL] [Abstract][Full Text] [Related]
5. Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis.
Zhang L; Wang CY; Yang R; Shi J; Fu R; Chen L; Klocker H; Zhang J
Urol Oncol; 2008; 26(6):634-40. PubMed ID: 18367130
[TBL] [Abstract][Full Text] [Related]
6. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI
Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379
[TBL] [Abstract][Full Text] [Related]
7. Quantitative polymerase chain reaction based on a dual-analyte chemiluminescence hybridization assay for target DNA and internal standard.
Verhaegen M; Christopoulos TK
Anal Chem; 1998 Oct; 70(19):4120-5. PubMed ID: 9784750
[TBL] [Abstract][Full Text] [Related]
8. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
[TBL] [Abstract][Full Text] [Related]
9. Quantitative reverse transcription-PCR assay with an internal standard for the detection of prostate-specific antigen mRNA.
Ylikoski A; Sjöroos M; Lundwall A; Karp M; Lövgren T; Lilja H; Iitiä A
Clin Chem; 1999 Sep; 45(9):1397-407. PubMed ID: 10471641
[TBL] [Abstract][Full Text] [Related]
10. A rapid real-time qRT-PCR assay for ovine beta-actin mRNA.
Bjarnadottir H; Jonsson JJ
J Biotechnol; 2005 May; 117(2):173-82. PubMed ID: 15823406
[TBL] [Abstract][Full Text] [Related]
11. Quantitative reverse transcriptase-polymerase chain reaction for prostate-specific antigen mRNA.
Galvan B; Christopoulos TK
Clin Biochem; 1997 Jul; 30(5):391-7. PubMed ID: 9253515
[TBL] [Abstract][Full Text] [Related]
12. The use of nested RT-PCR of prostate-specific membrane antigen in blood cells: implications for the detection of haematogenous neoplastic cells in patients with prostate adenocarcinoma.
Lucotte G; Mercier G; Burckel A
Mol Cell Probes; 1998 Dec; 12(6):421-5. PubMed ID: 9843660
[TBL] [Abstract][Full Text] [Related]
13. Quantification of insulin-like growth factor-1 (IGF-1) mRNA: development and validation of an internally standardised competitive reverse transcription-polymerase chain reaction.
Pfaffl M; Meyer HH; Sauerwein H
Exp Clin Endocrinol Diabetes; 1998; 106(6):506-13. PubMed ID: 10079033
[TBL] [Abstract][Full Text] [Related]
14. The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer.
Patel K; Whelan PJ; Prescott S; Brownhill SC; Johnston CF; Selby PJ; Burchill SA
Clin Cancer Res; 2004 Nov; 10(22):7511-9. PubMed ID: 15569981
[TBL] [Abstract][Full Text] [Related]
15. Dual-label detection of amplified products in quantitative RT-PCR assay using lanthanide-labeled probes.
Ylikoski A; Karp M; Lilja H; Lövgren T
Biotechniques; 2001 Apr; 30(4):832-6, 838, 840 passim. PubMed ID: 11314266
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells.
McIntyre IG; Spreckley K; Clarke RB; Anderson E; Clarke NW; George NJ
Br J Cancer; 2000 Oct; 83(8):992-7. PubMed ID: 10993644
[TBL] [Abstract][Full Text] [Related]
17. [Detection of MYCN mRNA in neuroblastoma cell lines by quantitative RT-PCR].
Feng C; Tang SQ; Wang JW; Liu LZ; Gao XN; Long H
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):47-50. PubMed ID: 17306077
[TBL] [Abstract][Full Text] [Related]
18. Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay.
Pötgens AJ; Lubsen NH; van Altena G; Schoenmakers JG; Ruiter DJ; de Waal RM
Thromb Haemost; 1994 Feb; 71(2):208-13. PubMed ID: 8191400
[TBL] [Abstract][Full Text] [Related]
19. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
Nikitina TV; Nazarova NIu; Tishchenko LI; Tuohimaa P; Sedova VM
Tsitologiia; 2003; 45(4):392-402. PubMed ID: 14520871
[TBL] [Abstract][Full Text] [Related]
20. Competitive cytokeratin 19 RT-PCR for quantification of breast cancer cells in blood cell suspensions.
Trummer A; Kadar J; Arseniev L; Petersen D; Ganser A; Lichtinghagen R
J Hematother Stem Cell Res; 2000 Apr; 9(2):275-84. PubMed ID: 10813542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
